216 related articles for article (PubMed ID: 20832663)
1. Stereotactic ablative radiotherapy should be combined with a hypoxic cell radiosensitizer.
Brown JM; Diehn M; Loo BW
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):323-7. PubMed ID: 20832663
[TBL] [Abstract][Full Text] [Related]
2. A phase I-B trial of the radiosensitizer: etanidazole (SR-2508) with radiosurgery for the treatment of recurrent previously irradiated primary brain tumors or brain metastases (RTOG Study 95-02).
Drzymala RE; Wasserman TH; Won M; Shaw E; Cmelak AJ; Loeffler J; Souhami L;
Radiother Oncol; 2008 Apr; 87(1):89-92. PubMed ID: 18342381
[TBL] [Abstract][Full Text] [Related]
3. RTOG #89-06: a phase I study to evaluate intraoperative radiation therapy and the hypoxic cell sensitizer etanidazole in locally advanced malignancies.
Halberg FE; Cosmatis D; Gunderson LL; Noyes RD; Hanks GR; Buswell L; Nagorney DM; Coleman CN
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):201-6. PubMed ID: 8270442
[TBL] [Abstract][Full Text] [Related]
4. Radiosensitization by a new potent nucleoside analog: 1-(1',3',4'-trihydroxy-2'-butoxy)methyl-2-nitroimidazole(RP-343).
Murayama C; Suzuki A; Sato C; Tanabe Y; Shoji T; Miyata Y; Nishio A; Suzuki T; Sakaguchi M; Mori T
Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):433-43. PubMed ID: 8514541
[TBL] [Abstract][Full Text] [Related]
5. Hypoxic cell sensitization: low-dose intrinsic radiosensitivity is predictive for etanidazole efficacy in a panel of human tumour cell lines.
Wouters BG; Sy AM; Skarsgard LD
Int J Radiat Biol; 1996 Dec; 70(6):719-33. PubMed ID: 8980670
[TBL] [Abstract][Full Text] [Related]
6. The hypoxic cytotoxin SR 4233 increases the effectiveness of radioimmunotherapy in mice with human non-Hodgkin's lymphoma xenografts.
Wilder RB; McGann JK; Sutherland WR; Waller EK; Minchinton AI; Goris ML; Knox SJ
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):119-26. PubMed ID: 8270432
[TBL] [Abstract][Full Text] [Related]
7. Hypoxic sensitizer and cytotoxin for head and neck cancer.
Lee DJ; Moini M; Giuliano J; Westra WH
Ann Acad Med Singap; 1996 May; 25(3):397-404. PubMed ID: 8876907
[TBL] [Abstract][Full Text] [Related]
8. Sensitization of Chinese hamster ovary cells to melphalan by etanidazole under intermittent hypoxia.
Bump EA; Coleman CN; Cerce BA; McGinnis DJ
Int J Radiat Oncol Biol Phys; 1992; 22(4):731-5. PubMed ID: 1531977
[TBL] [Abstract][Full Text] [Related]
9. Intervention with the hypoxic tumor cell sensitizer etanidazole in the combined modality treatment of limited stage small-cell lung cancer. A one-institution study.
Urtasun RC; Palmer M; Kinney B; Belch A; Hewitt J; Hanson J
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):337-42. PubMed ID: 9457818
[TBL] [Abstract][Full Text] [Related]
10. Radiosensitization of hypoxic cells in vivo by SR 2508 at low radiation doses: a preliminary report.
Brown JM; Yu NY
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1207-12. PubMed ID: 6236184
[TBL] [Abstract][Full Text] [Related]
11. [Radiosensitization by hypoxic cell radiosensitizer--present status of radiosensitizer].
Murayama C; Mori T
Gan No Rinsho; 1990 Oct; 36(13):2249-54. PubMed ID: 2147449
[TBL] [Abstract][Full Text] [Related]
12. Radiosensitization of a mouse tumor model by sustained intra-tumoral release of etanidazole and tirapazamine using a biodegradable polymer implant device.
Yapp DT; Lloyd DK; Zhu J; Lehnert S
Radiother Oncol; 1999 Oct; 53(1):77-84. PubMed ID: 10624857
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia and etanidazole alter radiation-induced apoptosis in HL60 cells but not in MOLT-4 cells.
Inanami O; Sugihara K; Okui T; Hayashi M; Tsujitani M; Kuwabara M
Int J Radiat Biol; 2002 Apr; 78(4):267-74. PubMed ID: 12020438
[TBL] [Abstract][Full Text] [Related]
14. Tumor volume-adapted dosing in stereotactic ablative radiotherapy of lung tumors.
Trakul N; Chang CN; Harris J; Chapman C; Rao A; Shen J; Quinlan-Davidson S; Filion EJ; Wakelee HA; Colevas AD; Whyte RI; Dieterich S; Maxim PG; Hristov D; Tran P; Le QT; Loo BW; Diehn M
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):231-7. PubMed ID: 22381907
[TBL] [Abstract][Full Text] [Related]
15. Stochastic Predictions of Cell Kill During Stereotactic Ablative Radiation Therapy: Do Hypoxia and Reoxygenation Really Matter?
Harriss-Phillips WM; Bezak E; Potter A
Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1290-7. PubMed ID: 27212197
[TBL] [Abstract][Full Text] [Related]
16. A comparison of radiosensitization by etanidazole and pimonidazole in mouse tumors.
Stone HB; Hirst VK; Cribbs R; Luu YH; Brown JM
Int J Radiat Oncol Biol Phys; 1991 May; 20(5):987-95. PubMed ID: 1827089
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic ablative radiotherapy (SABR) for non-small cell lung cancer.
Iyengar P; Westover K; Timmerman RD
Semin Respir Crit Care Med; 2013 Dec; 34(6):845-54. PubMed ID: 24258574
[TBL] [Abstract][Full Text] [Related]
18. In regard to Brown et al. (Int J Radiat Oncol Biol Phys 2010;78:323-327).
Koch CJ; Evans SM
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1604-5; author reply 1605. PubMed ID: 21741000
[No Abstract] [Full Text] [Related]
19. Results of a European randomized trial of Etanidazole combined with radiotherapy in head and neck carcinomas.
Eschwège F; Sancho-Garnier H; Chassagne D; Brisgand D; Guerra M; Malaise EP; Bey P; Busutti L; Cionini L; N'Guyen T; Romanini A; Chavaudra J; Hill C
Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):275-81. PubMed ID: 9308928
[TBL] [Abstract][Full Text] [Related]
20. Radiobiology of stereotactic ablative radiotherapy (SABR): perspectives of clinical oncologists.
Li S; Shen L
J Cancer; 2020; 11(17):5056-5068. PubMed ID: 32742453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
